Christopher Hall

Babraham Institute Flow cytometry Facility

Christopher has been working at the Babraham Institute since 2020 having previously been head of Flow Cytometry at EMBL in Rome and a Senior Research Assistant at the Cytometry Core Facility at the Sanger Institute in Cambridge, UK.  Prior to working in flow cytometry Christopher was involved in the RAGULA clinical trial at King’s College London and worked as a microbiologist at GSK and Findus UK. 

Christopher’s current flow cytometric obsession is full spectrum flow cytometry, from applying unmixing techniques to conventional machines, to applying spectral unmixing to novel biologic questions, to understanding the real world limitation of full spectrum where you may be better going back to conventional compensation.

In 2019 he was made an SRL Emerging Leader by the International Society for the Advancement of Cytometry.